QT
RPRX icon

Quantamental Technologies’s Royalty Pharma RPRX Stock Holding History

Quantamental Technologies’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-22,847
Closed -$702K – 534
2023
Q2 		$702K Buy
+22,847
New +$774K 0.29% 99
2023
Q1 		– Sell
-5,932
Closed -$234K – 591
2022
Q4 		$234K Buy
+5,932
New +$248K 0.11% 322

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantamental Technologies's RPRX Position: Q3 2023 in Review

Quantamental Technologies sold out of Royalty Pharma (RPRX) in Q3 2023, closing a stake of 22,847 shares — an estimated $702K sold.

Quantamental Technologies first reported a position in RPRX in Q4 2022 and held it in 2 quarters. The position peaked at $702K in Q2 2023. 313 funds tracked by Wall St. Rank hold RPRX as of Q3 2023.

  • Quantamental Technologies reported no remaining Royalty Pharma position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 22,847 Royalty Pharma shares in Q3 2023, an estimated $702K.
  • Quantamental Technologies first reported a position in Royalty Pharma in Q4 2022 and held it in 2 quarters.
  • Quantamental Technologies's Royalty Pharma position peaked at $702K in Q2 2023.
  • 313 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.